US Stock MarketDetailed Quotes

SNPHY Santen Pharmaceutical (ADR)

Watchlist
  • 9.645
  • +0.135+1.42%
15min DelayClose Apr 23 16:00 ET
3.50BMarket Cap20.01P/E (TTM)

Santen Pharmaceutical (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
8.69%77.03B
15.83%73.42B
10.46%72.39B
4.80%279.04B
12.48%79.25B
5.71%70.87B
-0.61%63.38B
0.84%65.53B
6.67%266.26B
3.89%70.46B
Operating revenue
8.69%77.03B
15.83%73.42B
10.46%72.39B
4.80%279.04B
12.48%79.25B
5.71%70.87B
-0.61%63.38B
0.84%65.53B
6.67%266.26B
3.89%70.46B
Cost of revenue
8.79%32.15B
7.04%29.43B
5.70%30.02B
2.99%112.95B
1.98%27.5B
-0.97%29.55B
5.99%27.5B
5.50%28.41B
11.66%109.67B
20.80%26.97B
Gross profit
8.61%44.88B
22.57%43.99B
14.11%42.37B
6.07%166.09B
19.00%51.75B
11.07%41.32B
-5.14%35.89B
-2.46%37.13B
3.44%156.59B
-4.41%43.49B
Operating expense
4.23%33.82B
-49.97%31.64B
2.85%29.62B
40.16%169.18B
31.52%44.69B
9.52%32.45B
124.41%63.24B
-0.40%28.79B
-13.29%120.7B
-43.56%33.98B
Selling and administrative expenses
-7.03%21.58B
-3.32%22.11B
8.44%21.07B
13.91%96.26B
27.21%30.76B
12.26%23.21B
19.07%22.87B
-4.99%19.43B
6.22%84.5B
-9.56%24.18B
-General and administrative expense
-7.03%21.58B
-3.32%22.11B
8.44%21.07B
13.91%96.26B
27.21%30.76B
12.26%23.21B
19.07%22.87B
-4.99%19.43B
6.22%84.5B
-9.56%24.18B
Research and development costs
-22.49%5.75B
-14.08%6.16B
-11.24%6.3B
7.28%28.3B
-12.66%6.62B
14.71%7.42B
15.28%7.17B
15.98%7.1B
9.39%26.38B
17.26%7.57B
-Depreciation and amortization
15.74%2.38B
-9.23%2.37B
-8.81%2.33B
-2.22%9.52B
-7.50%2.29B
-16.57%2.06B
10.36%2.61B
5.49%2.55B
-8.60%9.73B
-14.69%2.48B
Other operating expenses
13,253.13%4.27B
-93.77%1.91B
393.33%222M
3,309.44%38.63B
1,580.13%8.03B
-77.62%32M
6,367.86%30.59B
15.38%45M
-97.23%1.13B
-98.79%478M
Operating profit
24.63%11.06B
145.15%12.35B
52.99%12.75B
-108.61%-3.09B
-25.77%7.06B
17.14%8.87B
-383.49%-27.35B
-8.96%8.33B
194.49%35.89B
164.59%9.51B
Net non-operating interest income expense
68.87%-217M
-19.29%-334M
-30.11%882M
-125.94%-346M
-173.71%-631M
-382.19%-697M
-245.68%-280M
303.19%1.26B
1,039.44%1.33B
7,233.33%856M
Non-operating interest income
13.55%486M
18.75%152M
-24.19%1.05B
-54.66%1.15B
-88.05%159M
-20.74%428M
56.10%128M
134.75%1.39B
88.93%2.54B
304.56%1.33B
Non-operating interest expense
-37.51%703M
19.12%486M
36.59%168M
23.99%1.5B
66.32%790M
283.96%1.13B
150.31%408M
-55.60%123M
-18.75%1.21B
39.30%475M
Other net income (expense)
Income before tax
26.30%9.48B
139.77%11.21B
41.81%12.87B
-116.28%-5.8B
-41.73%5.79B
3.15%7.51B
-405.53%-28.18B
-1.06%9.07B
204.72%35.62B
166.68%9.94B
Income tax
38.09%2.18B
335.69%2.34B
3.24%2.46B
8.98%9.18B
128.73%4.69B
-29.49%1.58B
-76.55%538M
28.94%2.38B
228.92%8.43B
163.84%2.05B
Net income
23.17%7.31B
130.86%8.86B
55.52%10.41B
-155.11%-14.98B
-86.00%1.11B
17.63%5.93B
-514.46%-28.71B
-8.61%6.7B
197.93%27.19B
167.45%7.89B
Net income continuous Operations
23.17%7.31B
130.87%8.86B
55.52%10.41B
-155.11%-14.98B
-86.00%1.11B
17.63%5.93B
-514.46%-28.71B
-8.61%6.7B
197.93%27.19B
167.46%7.89B
Minority interest income
41.30%-27M
60.00%-4M
-106.25%-2M
-20.69%-35M
-145.83%-11M
-46M
-10M
313.33%32M
84.32%-29M
24M
Net income attributable to the parent company
22.67%7.33B
130.89%8.87B
56.30%10.41B
-154.92%-14.95B
-85.82%1.12B
18.54%5.98B
-514.32%-28.7B
-9.25%6.66B
192.32%27.22B
168.33%7.87B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
22.67%7.33B
130.89%8.87B
56.30%10.41B
-154.92%-14.95B
-85.82%1.12B
18.54%5.98B
-514.32%-28.7B
-9.25%6.66B
192.32%27.22B
168.33%7.87B
Basic earnings per share
33.76%20.72
132.56%24.6
66.35%27.93
-156.71%-38.6
-87.14%2.53
22.94%15.49
-533.51%-75.56
-8.55%16.79
192.15%68.07
167.26%19.68
Diluted earnings per share
33.64%20.66
132.45%24.52
66.07%27.85
-156.79%-38.6
-87.12%2.53
22.80%15.46
-534.50%-75.56
-8.56%16.77
192.22%67.97
167.16%19.65
Dividend per share
0
-3.18%16.0767
0
3.61%31.3372
2.22%14.7325
0
4.87%16.6047
0
7.59%30.2454
3.51%14.4125
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 8.69%77.03B15.83%73.42B10.46%72.39B4.80%279.04B12.48%79.25B5.71%70.87B-0.61%63.38B0.84%65.53B6.67%266.26B3.89%70.46B
Operating revenue 8.69%77.03B15.83%73.42B10.46%72.39B4.80%279.04B12.48%79.25B5.71%70.87B-0.61%63.38B0.84%65.53B6.67%266.26B3.89%70.46B
Cost of revenue 8.79%32.15B7.04%29.43B5.70%30.02B2.99%112.95B1.98%27.5B-0.97%29.55B5.99%27.5B5.50%28.41B11.66%109.67B20.80%26.97B
Gross profit 8.61%44.88B22.57%43.99B14.11%42.37B6.07%166.09B19.00%51.75B11.07%41.32B-5.14%35.89B-2.46%37.13B3.44%156.59B-4.41%43.49B
Operating expense 4.23%33.82B-49.97%31.64B2.85%29.62B40.16%169.18B31.52%44.69B9.52%32.45B124.41%63.24B-0.40%28.79B-13.29%120.7B-43.56%33.98B
Selling and administrative expenses -7.03%21.58B-3.32%22.11B8.44%21.07B13.91%96.26B27.21%30.76B12.26%23.21B19.07%22.87B-4.99%19.43B6.22%84.5B-9.56%24.18B
-General and administrative expense -7.03%21.58B-3.32%22.11B8.44%21.07B13.91%96.26B27.21%30.76B12.26%23.21B19.07%22.87B-4.99%19.43B6.22%84.5B-9.56%24.18B
Research and development costs -22.49%5.75B-14.08%6.16B-11.24%6.3B7.28%28.3B-12.66%6.62B14.71%7.42B15.28%7.17B15.98%7.1B9.39%26.38B17.26%7.57B
-Depreciation and amortization 15.74%2.38B-9.23%2.37B-8.81%2.33B-2.22%9.52B-7.50%2.29B-16.57%2.06B10.36%2.61B5.49%2.55B-8.60%9.73B-14.69%2.48B
Other operating expenses 13,253.13%4.27B-93.77%1.91B393.33%222M3,309.44%38.63B1,580.13%8.03B-77.62%32M6,367.86%30.59B15.38%45M-97.23%1.13B-98.79%478M
Operating profit 24.63%11.06B145.15%12.35B52.99%12.75B-108.61%-3.09B-25.77%7.06B17.14%8.87B-383.49%-27.35B-8.96%8.33B194.49%35.89B164.59%9.51B
Net non-operating interest income expense 68.87%-217M-19.29%-334M-30.11%882M-125.94%-346M-173.71%-631M-382.19%-697M-245.68%-280M303.19%1.26B1,039.44%1.33B7,233.33%856M
Non-operating interest income 13.55%486M18.75%152M-24.19%1.05B-54.66%1.15B-88.05%159M-20.74%428M56.10%128M134.75%1.39B88.93%2.54B304.56%1.33B
Non-operating interest expense -37.51%703M19.12%486M36.59%168M23.99%1.5B66.32%790M283.96%1.13B150.31%408M-55.60%123M-18.75%1.21B39.30%475M
Other net income (expense)
Income before tax 26.30%9.48B139.77%11.21B41.81%12.87B-116.28%-5.8B-41.73%5.79B3.15%7.51B-405.53%-28.18B-1.06%9.07B204.72%35.62B166.68%9.94B
Income tax 38.09%2.18B335.69%2.34B3.24%2.46B8.98%9.18B128.73%4.69B-29.49%1.58B-76.55%538M28.94%2.38B228.92%8.43B163.84%2.05B
Net income 23.17%7.31B130.86%8.86B55.52%10.41B-155.11%-14.98B-86.00%1.11B17.63%5.93B-514.46%-28.71B-8.61%6.7B197.93%27.19B167.45%7.89B
Net income continuous Operations 23.17%7.31B130.87%8.86B55.52%10.41B-155.11%-14.98B-86.00%1.11B17.63%5.93B-514.46%-28.71B-8.61%6.7B197.93%27.19B167.46%7.89B
Minority interest income 41.30%-27M60.00%-4M-106.25%-2M-20.69%-35M-145.83%-11M-46M-10M313.33%32M84.32%-29M24M
Net income attributable to the parent company 22.67%7.33B130.89%8.87B56.30%10.41B-154.92%-14.95B-85.82%1.12B18.54%5.98B-514.32%-28.7B-9.25%6.66B192.32%27.22B168.33%7.87B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 22.67%7.33B130.89%8.87B56.30%10.41B-154.92%-14.95B-85.82%1.12B18.54%5.98B-514.32%-28.7B-9.25%6.66B192.32%27.22B168.33%7.87B
Basic earnings per share 33.76%20.72132.56%24.666.35%27.93-156.71%-38.6-87.14%2.5322.94%15.49-533.51%-75.56-8.55%16.79192.15%68.07167.26%19.68
Diluted earnings per share 33.64%20.66132.45%24.5266.07%27.85-156.79%-38.6-87.12%2.5322.80%15.46-534.50%-75.56-8.56%16.77192.22%67.97167.16%19.65
Dividend per share 0-3.18%16.076703.61%31.33722.22%14.732504.87%16.604707.59%30.24543.51%14.4125
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg